PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma

被引:0
|
作者
Ki Hyung Kim
Kyung Un Choi
Ahrong Kim
So Jung Lee
Jung Hee Lee
Dong Soo Suh
Byung-su Kwon
Chungsu Hwang
机构
[1] Pusan National University Hospital,Department of Obstetrics and Gynecology
[2] Pusan National University Hospital,Department of Pathology
[3] Pusan National University Yangsan Hospital,Department of Pathology
[4] Research Institute for Convergence of Biomedical Science and Technology,undefined
来源
Journal of Ovarian Research | / 12卷
关键词
Ovarian cancer; Tumor-infiltrating lymphocyte; PD-L1; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
    Kim, Ki Hyung
    Choi, Kyung Un
    Kim, Ahrong
    Lee, So Jung
    Lee, Jung Hee
    Suh, Dong Soo
    Kwon, Byung-su
    Hwang, Chungsu
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [2] PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
    de la Fuente, Laura Martin
    Westbom-Fremer, Sofia
    Arildsen, Nicolai Skovbjerg
    Hartman, Linda
    Malander, Susanne
    Kannisto, Paivi
    Masback, Anna
    Hedenfalk, Ingrid
    VIRCHOWS ARCHIV, 2020, 477 (01) : 83 - 91
  • [3] Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma
    Nie, Hanxiao
    He, Tao
    Wang, Li
    Zhang, Ling
    ONCOTARGETS AND THERAPY, 2021, 14 : 1377 - 1385
  • [4] Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma
    Hu, Jie
    Toyozumi, Takeshi
    Murakami, Kentaro
    Endo, Satoshi
    Matsumoto, Yasunori
    Otsuka, Ryota
    Shiraishi, Tadashi
    Iida, Shinichiro
    Morishita, Hiroki
    Makiyama, Tenshi
    Nishioka, Yuri
    Uesato, Masaya
    Hayano, Koichi
    Nakano, Akira
    Matsubara, Hisahiro
    CANCER MEDICINE, 2024, 13 (17):
  • [5] PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
    Chen, Hao
    Molberg, Kyle
    Strickland, Amanda L.
    Castrillon, Diego H.
    Carrick, Kelley
    Jiang, Qingping
    Niu, Shuang
    Rivera-Colon, Glorimar
    Gwin, Katja
    Hinson, Stacy
    Lea, Jayanthi
    Miller, David S.
    Zheng, Wenxin
    Lucas, Elena
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (08) : 1050 - 1060
  • [6] Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pleomorphic Lobular Breast Carcinoma
    Goker, Menekse
    Deblaere, Stephanie
    Denys, Hannelore
    Vergauwen, Glenn
    Naert, Eline
    Veldeman, Liv
    Monten, Chris
    Van den Broecke, Rudy
    Van Dorpe, Jo
    Braems, Geert
    Van de Vijver, Koen
    CANCERS, 2023, 15 (11)
  • [7] PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
    Webb, John R.
    Milne, Katy
    Kroeger, David R.
    Nelson, Brad H.
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 293 - 302
  • [8] Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma
    Hwang, Chungsu
    Lee, So Jung
    Lee, Jung Hee
    Kim, Ki Hyung
    Suh, Dong Soo
    Kwon, Byung-Su
    Choi, Kyung Un
    ONCOLOGY LETTERS, 2019, 17 (05) : 4557 - 4565
  • [9] PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
    Cao, Jinfeng
    Brouwer, Niels J.
    Richards, Kate E.
    Marinkovic, Marina
    van Duinen, Sjoerd
    Hurkmans, Daan
    Verdegaal, Els M. E.
    Jordanova, Ekaterina S.
    Jager, Martine J.
    ONCOTARGET, 2017, 8 (33) : 54722 - 54734
  • [10] Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
    Darb-Esfahani, Silvia
    Kunze, Catarina Alisa
    Kulbe, Hagen
    Sehouli, Jalid
    Wienert, Stephan
    Lindner, Judith
    Budczies, Jan
    Bockmayr, Michael
    Dietel, Manfred
    Denkert, Carsten
    Braicu, Ioana
    Joehrens, Korinna
    ONCOTARGET, 2016, 7 (02) : 1486 - 1499